I am a
Home I AM A Search Login

Papers of the Week


Papers: 2 Mar 2024 - 7 Mar 2024


2024 Mar 01


J Biomater Appl


38427917

Rizatriptan benzoate-loaded dissolving microneedle patch for management of acute migraine therapy.

Authors

Zhong C, Zhang X, Sun Y, Shen Z, Mao Y, Liu T, Wang R, Nie L, Shavandi A, Yunusov KE, Jiang G

Abstract

In this study, dissolving microneedles (MNs) using polyvinyl alcohol (PVA) and poly (1-vinylpyrrolidone-co-vinyl acetate) (P(VP-co-VA)) as matrix materials were developed for transdermal delivery of rizatriptan benzoate (RB) for acute migraine treatment. permeation studies were conducted to assess the feasibility of the as-fabricated dissolving MNs to release RB. Drug skin penetration were tested by Franz diffusion cells, showing an increase of the transdermal flux compared to passive diffusion due to the as-fabricated dissolving MNs having a sufficient mechanical strength to penetrate the skin and form microchannels. The pharmacological study showed that RB-loaded dissolving MNs significantly alleviated migraine-related response by up-regulating the level of 5-hydroxytryptamine (5-HT) and down-regulating the levels of calcitonin gene-related peptide (CGRP) and substance P (SP). In conclusion, the RB-loaded dissolving MNs have advantages of safety, convenience, and high efficacy over conventional administrations, laying a foundation for the transdermal drug delivery system treatment for acute migraine.